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Abstract
Adult Ibsp-knockout mice (BSP2/2) display shorter stature, lower bone turnover and higher trabecular bone mass than wild
type, the latter resulting from impaired bone resorption. Unexpectedly, BSP knockout also affects reproductive behavior, as
female mice do not construct a proper "nest" for their offsprings. Multiple crossing experiments nonetheless indicated that
the shorter stature and lower weight of BSP2/2 mice, since birth and throughout life, as well as their shorter femur and
tibia bones are independent of the genotype of the mothers, and thus reflect genetic inheritance. In BSP2/2 newborns,
mCT analysis revealed a delay in membranous primary ossification, with wider cranial sutures, as well as thinner femoral
cortical bone and lower tissue mineral density, reflected in lower expression of bone formation markers. However,
trabecular bone volume and osteoclast parameters of long bones do not differ between genotypes. Three weeks after birth,
osteoclast number and surface drop in the mutants, concomitant with trabecular bone accumulation. The growth plates
present a thinner hypertrophic zone in newborns with lower whole bone expression of IGF-1 and higher IHH in 6 days old
BSP2/2 mice. At 3 weeks the proliferating zone is thinner and the hypertrophic zone thicker in BSP2/2 than in BSP+/+
mice of either sex, maybe reflecting a combination of lower chondrocyte proliferation and impaired cartilage resorption. Six
days old BSP2/2 mice display lower osteoblast marker expression but higher MEPE and higher osteopontin(Opn)/Runx2
ratio. Serum Opn is higher in mutants at day 6 and in adults. Thus, lack of BSP alters long bone growth and membranous/
cortical primary bone formation and mineralization. Endochondral development is however normal in mutant mice and the
accumulation of trabecular bone observed in adults develops progressively in the weeks following birth. Compensatory
high Opn may allow normal endochondral development in BSP2/2 mice, while impairing primary mineralization.
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Introduction
Members of the SIBLING (Small Integrin-Binding Ligand, N-
linked Glycoprotein) family [1] are known to play key biological
roles in the development, turnover and mineralization of bone
and dentin. Among this family, bone sialoprotein (BSP, IBSP, [2])
as well as osteopontin (Opn, SPP1, [3]) are strongly expressed by
osteoblasts, osteoclasts and hypertrophic chondrocytes. Incipient
expression of BSP, which is particularly abundant in sites of
primary bone formation [4][5] coincides with the initial
formation of membranous and endochondral bone, maximal
level being reached during the formation of embryonic bone [5].
We previously showed that adult mice (16 week old) with a
knockout of the Ibsp gene (BSP2/2) are shorter than their wild
type counterparts and display a low level of bone remodeling,
with both bone formation and mineralization severely impaired in
vivo and in in vitro models [6]. We also showed that BSP2/2 mice
display lower osteoclast numbers and surfaces in vivo [6], and that
osteoclast recruitment and activity in vitro were impaired in the
absence of BSP [7]. Interestingly, and despite their low level of
bone remodeling, adult BSP2/2 mice present a higher
trabecular bone mass than the BSP+/+ [6], which raises
questions about the development of the BSP2/2 adult
phenotype.
In this study, we monitored the skeletal development of
BSP2/2 and BSP+/+ mice, asking when and how the short
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size and high trabecular bone of the adult were set up.
BSP2/2 mothers display an abnormal pup care behavior,
which does not impair the growth of wild type and heterozy-
gous mice, showing that the skeletal phenotype of BSP2/2
mice is gene-based. We show that BSP2/2 mice are born with
their shorter stature and that the lack of BSP alters long bone
growth, membranous/cortical primary bone formation and
mineralization, as well as cartilage and osteoblast gene
expression, with low bone IGF-1 and high levels of Opn.
However, the endochondral development is normal in mutant
mice and the accumulation of trabecular bone observed in the
adults develops progressively in the weeks following birth.
Material and Methods
Production of BSP2/2 mice
BSP Knock-out mice were generated as described in [6].
Briefly, exons II–III of the mouse Ibsp gene were replaced by a
PGKneo cassette that created a null allele in mouse embryonic
stem (ES) cells (R1 passage 8; kindly provided by Dr. Andras
Na¨gy [8]). After selection, positive clones were used to
generate chimeric mice which were crossed to albino CD1
outbred females, and a chimeric male with germline transmis-
sion of the mutation was used to establish offspring on a 129/
CD1 background. BSP2/2 mice are viable and fertile; their
phenotype has been extensively described elsewhere [6].
Animal reproduction and genotyping
Wild type and mutant mice were kept as separate lines,
except for cross-foster experiments. They were housed under
controlled conditions at 2362uC on a 12-h light/12-h dark
cycle, fed with A03 food preparation (SAFE, Avry, France) and
given tap water with free access. Whenever required, the
offsprings genotyping was performed by PCR (Qiagen,
Mannhein,Germany) on genomic DNA Tail isolated with
Direct PCR Lysis Reagent (Viagen, Biotech Inc., Los Angeles,
Ca, USA) plus proteinase K (Euromedex, France). The PCR
reaction was performed with the following primers: BSP-
forward = AGGACTAGGGGTCAAACAC, BSP-reverse = A-
GTAGCGTGGCCGGTACTTA, and PKGneo (RLP 290) = T-
CGCCTTCTTGACGAGTTCTGAG, in the appropriate
PCR conditions. Results were analyzed by running the samples
in a 2% agarose (Sigma, France) gel electrophoresis. Expected
bands were at 481 bp for BSP+/+, 550 bp for BSP2/2 and
both for BSP+/2 samples.
Sampling procedures
Newborn mice were killed by hypothermia, and fixed in 100%
EtOH for 24 h. Three, 10 and 16 week old mice were killed by
cervical dislocation and the femurs and tibias dissected out and
fixed in 3.7% paraformaldehyde in PBS. Six days, 35 days and 12
month old animals were killed by decapitation for serum
collection and storage at 280uC. For 6 days old mice, blood
was collected from 5–6 individuals and pooled in the same tube
(N in the results thus refers to the number of blood pools assayed).
In some 6 days old mice, long bones were dissected out and
processed for QRT-PCR as described below. The procedures for
the care and killing of the animals were in accordance with the
European Community Standards on the care and use of
laboratory animals (Ministe`re de l9Agriculture, France, Authori-
zation 04827). All animal experiments were approved by the
"Comite´ du Bien Etre Animal" of the medical faculty exper-
imentation platform (PLEXAN, Universite´ Jean Monnet, Saint-
Etienne, France).
Morphological and morphometric assessment
Fixed newborn mice were dissected, skinned, eviscerated and
dehydrated in 100% acetone for 24 h. The samples were then
processed for whole mount skeletal preparation according to
established methods [9]. Alcian blue was used to stain cartilage
and Alizarin red was used to stain calcified tissues.
To check whether the altered behavior of BSP2/2 mothers
had impact on their bone phenotype, multiple crossing
experiments were performed. We first crossed BSP+/+ with
BSP2/2 mice to generate heterozygous progeny. Then,
female BSP2/2 mice were crossed with heterozygous
BSP+/2 male mice, giving a mixed progeny of BSP2/2
and BSP+/2 pups. Finally, we crossed all heterozygous mice
to obtain a Mendelian mix of BSP+/+, 2/2 and +/2
progeny. In all configurations, we compared length and weight
growth curves between 8 and 35 days, as well as femur length
at 40 days in pups of different genotypes raised by BSP+/+,
+/2 or 2/2 mothers. To do this, mice were tagged for
identification at day 7 after birth, and then weighted every
other day with a 0.1 g precision scale. Their length was
measured (nose to tail insertion) with an electronic digital
Table 1. PCR primer sequences in 59-39 direction.
Gene Forward Reverse Sequence Bank ID
Runx2 ccgggaatgatgagaactac Tgtctgtgccttcttggttc NM_009820.4
Osx atggcgtcctctctgcttg aaggtcagcgtatggcttct NM_130458.3
Ocn ctctgacctcacagatgccaa ctggtctgatagctcgtcaca NM_007541.2
DMP1 ttcgagaacttcgctgaggt ttgtggtatctggcaactgg NM_016779.2
MEPE ccccaagagcagcaaaggta ctccgctgtgacatcccttta NM_053172.2
Opn cccggtgaaagtgactgattc atggctttcattggaattgc NM_009263.2
PTHrP ctggttcagcagtggagtgt cctccgaggtagctctgatt NM_008970.3
IHH cgctgcaaggaccgtctgaa agcggccgaatgctcagact NM_010544.2
IGF-1 cttcaccagctccaccacag cagctccggaagcaacactc NM_010512.4
GAPDH aaggtcggtgtgaacggatt attctcggccttgactgtgc NM_008084
The meaning of the abbreviations is explained in the text.
doi:10.1371/journal.pone.0095144.t001
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caliper. At day 40, mice of all genotypes were killed and the
femurs and tibias collected (see above) were measured with a
caliper. In all cases, we took care to compare mice from litters
of similar sizes.
Tridimensional microtomography (mCT)
Newborn whole skeletons and femurs from 3, 10 and 16
week old BSP+/+ and BSP2/2 mice were scanned with a
high resolution mCT (Viva CT40, Scanco Medical, Bassers-
dorf, Switzerland). Newborn mice, were scanned at 45 keV
with a 10 mm cubic resolution. For isolated femurs, the
secondary spongiosa of trabecular bone was scanned within
the metaphysis below the growth plate and the cortical bone
was scanned in the diaphysis, at 55 keV with a 10 mm cubic
resolution. Three-dimensional reconstructions were generated
using the following parameters for newborn whole skeletons:
Sigma, 1.2; Support, 2; Threshold, 225. Parameters were;
Sigma, 1.2; Support, 2; Threshold, 276 for trabecular bone
and Sigma, 1.2; Support, 2; Threshold, 280 for cortical bone of
3 week old femurs, and Sigma, 1.2; Support, 2; Threshold, 245
for trabecular bone and Sigma, 1.2; Support, 2; Threshold,
280 for cortical bone of 10 and 16 weeks femurs. The
structural parameters of trabecular bone, bone volume (BV/
TV), trabecular thickness (Tb.Th), trabecular number (Tb.N),
trabecular separation (Tb.Sp), and structure model index
(SMI) were generated from a set of 80 sections, without
assuming a constant model, as previously described [10].
Cortical area and thickness (Ct.Th) were calculated by
integration of the value on each transverse section of a set of
30 chosen in the midshaft area.
Bone histology and histomorphometry
Excised and fixed femurs and the lower half of fetuses were
dehydrated in acetone and embedded in methylmethacrylate.
Longitudinal slices were performed with a Jung model K
microtome (Carl Zeiss, Heidelberg, Germany) and used for
modified Goldner staining, tartrate-resistant acid phosphatase
(TRAP) staining of osteoclasts and Von Kossa staining of
calcified tissues. Trabecular bone volume (BV/TV), osteoı¨d
surface (OS/BS), growth plate thickness and hypertrophic zone
thickness were measured on Goldner stained sections. Osteo-
clast number (Oc.N/BS) and osteoclast surface (Oc.S/B.Ar)
were measured on TRAP stained sections. ROI for bone
parameters were evaluated in the secondary spongiosa of
trabecular bone within the metaphysis below the growth plate
as shown in the figure.
RNA extraction and QRT-PCR analysis
Both femur and tibia (in connection and including articu-
lations and growth plates) of 6 days old mice were haversted
after death, cleaned of surrounding soft tissue and frozen in
liquid nitrogen. Bone samples were crushed with a mixer mill
(Sartorius,Go¨ttingen, Germany) using steel balls. RNA was
extracted from the bone powder with Tri-Reagent (Sigma),
then purified on columns according to the manufacturer’s
instructions (RNeasy Plus Mini Kit, Qiagen, Hilden, Ger-
many). RNA amounts were assessed with the Ribogreen kit
(Invitrogen, Life Technologies, Eugene, OR, USA) and their
quality checked with the Experion automated electrophoresis
station (BIO-RAD, Hercules, CA, USA). Messenger RNA was
reverse-transcribed (iScript cDNA synthesis Kit, Biorad)
according to manufacturer’s instruction, then 400 ng of cDNA
were amplified through QRT-PCR using the SYBR Green I
dye (Lightcycler faststart DNA master SYBR green I, Roche,
Germany). Expression of the genes of interest was normalized
to glyceraldehyde-3-phosphate dehydrogenase (GADPH). The
expression of the housekeeping gene did not differ at either age
in either genotype. Primer sequences of the transcripts
amplified are listed in Table 1.
ELISA assays
Serum samples were assayed with a commercial ELISA kits
for Opn (DuoSet mouse Osteopontin, R&D Systems, Minne-
apolis, MN, USA) used according to the manufacturer’s
Figure 1. Newborn morphology and growth of BSP+/+ and
BSP2/2mice. (A) general aspect of BSP+/+ (+/+) and BSP 2/2 (2/2)
newborn mice. (B) Kinetics of weight gain during the growth of BSP+/+
and BSP2/2mice. M, males; F, females. Data are Mean6SEM of N= 4 to
31 mice. Note the log scale.
doi:10.1371/journal.pone.0095144.g001
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instructions. Serum was obtained as described in
sampling procedures. Each sample was run in duplicate in
the assay.
Statistical Analysis
All results are presented as mean 6 SEM. To accommodate for
sample size variations according to the experiment (cf. Figure
Legends), and N values sometimes too small to establish normality,
all data were submitted to Kruskall and Wallis with post-test or
Mann-Whitney U test (see Legends), performed with the INSTAT
software (version 3.00 for Windows 95, GraphPad Software, San
Diego, CA).
Results
Developmental effects of the BSP gene knockout
BSP2/2 mice were significantly smaller than BSP+/+, since
birth (Fig. 1A) and up to senescence as shown by weight curves
(Fig. 1B) and as previously reported from long bone measurements
[6].
Delayed skeletal mineralization in mice lacking BSP
General aspect or whole mount skeletal preparations of
newborn BSP+/+ and BSP2/2 mice revealed no differences in
morphology nor endochondral ossification stage (Fig. 2A), nor did
histological observations indicate any delay in the appearance of
ossification centers (not shown). However, the skeletal elements of
newborn BSP2/2 mice were under-mineralized respective to
Figure 2. Skeletal development and mineralization of newborn BSP+/+ and BSP2/2mice. (A) Skeletal preparation (alcian blue/alizarin red
staining) of BSP+/+ (+/+) and BSP 2/2 (2/2) E19 mice. (B) 3D mCT reconstruction of whole newborn +/+ and 2/2 mice, showing undermineralized
fingers (arrows and black-bordered detailed pictures), and (C) high magnification of the heads showing the widened sutures (arrows).
doi:10.1371/journal.pone.0095144.g002
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BSP+/+, as showed in 3D mCT reconstructions by missing finger
bones (Fig. 2B) porous skull elements and widened sutures
(Fig. 2C).
The altered reproductive behavior of BSP2/2 mothers
does not bear on the expression of the mutant
phenotype
Observation of weaning wild type and mutant mice revealed
that mothers lacking BSP display an aberrant behavior. Pieces
of soft paper were put in the cages 5 days before birth to
provide the mothers with proper material for nest construction
[11]. While BSP+/+ mice built nests for their offsprings by
carefully dilacerating the paper material, BSP2/2 mothers
did not tear the paper apart and hardly gathered the fragments
around their pups (Fig. 3A). Although this was not quantified,
BSP2/2 mothers also spent more time wandering in the cages
and less time in contact with the pups than the BSP+/+.
Concerned that altered care for the offsprings might be a
confounding factor, we analyzed the effect of the genotype of
mothers on the development of the BSP2/2 phenotype in the pups
and designed cross-fostering experiments. First, we crossed mutant
and wild type mice and assessed the growth curve of heterozygous
offsprings. As shown in Figure 3B, the mother’s genotype did not
affect the rate of weight or length accrual during the weaning
period. Also, femur and tibia length of 40 days old BSP+/2 mice
did not differ whether they were raised by +/+ or 2/2 mothers
(Fig. 3C). Second, we crossed BSP2/2 females with +/2 males
and measured femur and tibia length at day 40; as expected and
published before [6], we found that the long bones of 2/2
offsprings were shorter than those of +/2 siblings of the same2/2
mother (Fig. 3D). Conversely, the crossing of +/2 mice gave a
mendelian ratio (not shown) of +/+,2/2 and +/2 offsprings, with
significantly lower body weight and femur length only in the
BSP2/2 (Fig. 3E), reflecting the effect of the mutation and its
recessive character, as previously described [6]. Therefore, no
mother effect was observed for the skeletal impact of the absence of
BSP, which appears to be strictly gene based.
BSP2/2 mice display altered growth plate parameters
In newborn BSP2/2 mice, growth plate thickness was
significantly lower than in BSP+/+, and the hypertrophic zone
was thinner (Fig. 4). At 3 weeks of age, growth plate thickness
was similar in both genotypes, but with a thicker hypertrophic
zone and a thinner proliferating zone in both sexes. No
difference was observed between the two genotypes in the
growth plates of 10 week old femurs, nor at 16 weeks when
growth activity was residual and the plates were starting to
mineralize (Fig. 4).
Newborn BSP2/2 mice display thinner,
hypo-mineralized cortical bone
Microtomographic analysis of femurs in newborn BSP+/+
and BSP2/2 mice showed that mutant bones had a lower
global bone volume, explained by a thinner cortical envelope
(see also pictures in Fig. 5C) as well as a lower tissue mineral
density (Fig. 5A), as previously reported [6]. In contrast,
histomorphometric analysis of femoral trabecular bone showed
no difference in BV/TV between mutant and wild type
(Fig. 5B, C). Osteoclast parameters, Oc.S/BS and Oc.N/B.Ar
did not differ between newborn BSP2/2 and BSP+/+ mice
(Fig. 5B).
Expression of factors regulating long bone growth is
altered in BSP2/2 mice
QRT-PCR analysis of 6 days old mouse bones showed that
PTHrP expression was decreased, albeit not significantly (P = 0.11)
in 6 days old BSP2/2 long bones, and IHH expression was
increased (Fig. 6A). Bone expression of IGF-1, a major growth-
promoting signal for skeletal development, was decreased in
mutant bones (Fig. 6A).
BSP2/2 mice display a decrease in bone formation
markers and higher levels of circulating osteopontin
In 6 days old pups, the expression of early osteoblast
markers, Runx2 and Osx was decreased as well as that of the
late marker Ocn (Fig. 6B) and the SIBLING DMP1 (Fig. 6C).
Interestingly, the expression of the other SIBLING protein
MEPE was found to be increased in BSP2/2 long bones
(Fig. 6C), while expression of Opn was decreased when
normalized on GAPDH but was 5 fold increased when
normalized on Runx2 (Fig 6C). ELISA assay of Opn in the
blood of 6 day old mice showed significantly higher values (+
64%) in BSP2/2 than in the BSP+/+, and interestingly they
were still higher (+48%) in the blood of aged, 12 month old
mutant mice whose mineral density is no longer different from
the wild type ([6], Fig. 6D).
Progressive development of the adults BSP2/2 bone
phenotype
As early as 3 weeks after birth, and at 10 and 16 weeks of age
trabecular BV/TV in the femurs of BSP2/2 mice was higher
than in BSP+/+, in both male and female (Fig. 7). This was
concomitant with a decrease of osteoclast parameters, both
Oc.S/BS and Oc.N/B.Ar in mutant mice of both sexes.
Cortical bone of BSP2/2 mice became transiently thicker at 3
weeks respective to BSP+/+, to become thinner at 10 and 16
weeks of age (Fig. 7). Interestingly, OS/BS values were
significantly lower in BSP2/2 mice at 3 and 10 weeks of
age, to become higher than in BSP+/+ at 16 weeks (Fig. 7), as
previously published [6]. The impact of the BSP2/2
mutation on post-natal skeletal development is summarized
in Table 2.
Discussion
In this study, we show that mice lacking BSP are smaller
than their wild type counterparts since birth and throughout
their developmental process. The study of their skeleton did
Figure 3. Impact of the lack of BSP on mother’s behavior. (A) Pictures of BSP+/+ and BSP2/2 mothers with pups; note the well formed "nest"
in the wild type mouse cage as opposed to the untouched and spread out pieces of soft paper in the mutant mouse cage (arrows). Note: the 129 sv/
CD1 background is outbred, leading to hair color variability. (B) Body length (left) and weight (right) increase in the 30 first days of growing male and
female BSP+/2mice from BSP+/+ (#, N = 7 pups) and BSP2/2mothers (N, N = 6 pups). (C) Femur and tibia length of 40 days old BSP+/2mice from
either BSP+/+ or BSP2/2mothers. (D) Femur and tibia length of 40 days old BSP+/2 (N = 6) and BSP2/2mice (N= 6) from BSP2/2mothers crossed
with BSP+/2 males. (E) Body weight and femur length of 40 days old BSP+/+ (N= 7), BSP2/2 (N = 11) and BSP+/2 mice (N= 22) from BSP+/2
parents. Data are Mean6SEM; *: p,0.05 vs BSP+/+ and/or BSP+/2, Mann-Whitney U Test or (E) Kuskall-Wallis with post-test.
doi:10.1371/journal.pone.0095144.g003
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Figure 4. Growth plate kinetics of newborn, 3 week old, 10 and 16 week old BSP+/+ and BSP2/2mice. Data are Mean6SEM of N= 7 to 8
newborn and 4 to 6 adult mice; *:p,0.05, **:p,0.001 vs BSP+/+ Mann-Whitney U Test. Micrographs of the growth plate in the distal femur of BSP+/+
and BSP2/2 newborn and 3, 10 and 16 week old mice.
doi:10.1371/journal.pone.0095144.g004
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Figure 5. Morphology and morphometry of the long bones in newborn BSP+/+ and BSP2/2 mice. (A) 3D mCT reconstruction and
morphometry of newborn whole femurs from BSP+/+ (+/+) and 2/2 newborn mice. (B) Histomorphometry of trabecular bone in newborn femurs
from +/+ and 2/2 mice. Data are Mean6SEM of N=4 to 10 mice; *:p,0.05, **:p,0.01 Vs +/+, Mann-Whitney U Test. (C) Micrographs of Goldner’s
trichrome and Von Kossa staining of BSP+/+ and BSP2/2 newborn femur sagittal sections. Yellow polygon: ROI for histomorphometry of the
trabecular bone. Bar = 400 mm.
doi:10.1371/journal.pone.0095144.g005
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not show any other morphological effect of the mutation.
However, the amount of primary mineralized bone is lower in
the skull and long bone cortex of BSP2/2 newborn mice.
Moreover, and as previously shown [6], the volumetric bone
density in BSP2/2 newborns is lower than in BSP+/+.
Our study was further complicated by the unexpected discovery
that weaning female BSP2/2mice do not display normal care for
their pups. That the lack of BSP, an extracellular matrix protein
would affect behavior is both surprising and novel. To the best of
our knowledge, the only other case of a behavioral impact of the
absence of a SIBLING member is the "circling behavior" and
hyper-reactivity to touch of DMP12/2 mice [12]. This has been
ascribed to the under-mineralization of the vestibular bone, which
would alter sensory (balance) perception in this line [12]. In a
recent analysis of the genetics of nest building in two inbred mouse
strains, chromosome 5 -which carries the SIBLING locus in mice-
displayed no direct effect QTL, but was found involved in several
epistatic effects [13]. Extensive studies, including ethological, will
be required to assess the full impact of the BSP2/2 mutation on
mouse behavior and evaluate whether it reflects a direct (e.g.
neurological) effect or an indirect, e.g. sensory one as for the
DMP1 knockout. Because we kept the mutants as a separate line,
and the mother’s aberrant behavior might have a thermic and/or
trophic impact on the pup’s development, we conducted a
thorough analysis of the growth of BSP+/+, +/2 and 2/2 mice
from mothers of various genotype. Of note, variations in growth
kinetics were observed according to the number of pups (not
shown) as was expected [14], and we took care to compare
genotype effects between litters of similar sizes. The results (Fig. 3)
show without doubt that the phenotype of the mutant mice only
reflects the absence of the BSP protein, and is thus independent
from the mother’s genetics.
BSP is expressed in hypertrophic chondrocytes [15], and given
its effects on endothelial cells migration on the one hand [16] and
hydroxyapatite nucleation on the other hand [17], one could
expect an effect of the lack of BSP on the onset of endochondral
ossification. Surprisingly, this process does not seem to be affected
in BSP2/2 mice, as no delay appears in the onset of ossification
centers, and trabecular BV/TV and osteoclast parameters in
newborn femurs are similar between genotypes. This suggests that
some compensatory mechanisms may exist to override the absence
of BSP. In particular, other SIBLING proteins are expressed by
hypertrophic chondrocytes and osteoblasts in the chondro-osseous
border, and are thought to play an important role in endochondral
bone ossification [18] (see below). Further analyzes are needed to
determine the exact role of BSP in the onset of endochondral
ossification and the possible compensatory effects of other
SIBLING members.
Nonetheless, newborn BSP2/2 femurs display thinner growth
plates, indicating that the long bone growth kinetics is already
altered at that stage, as also witnessed by the slightly smaller size
and lighter weight of newborn mutant mice. Bone growth is
achieved by proliferation and hypertrophy of chondrocytes, then
removal of the cartilage template by osteoclasts and its replace-
ment with woven bone by osteoblasts. This process is subject to a
regulation loop involving PTHrP secreted by perichondrial cells
and resting chondrocytes, which promotes chondrocyte prolifer-
ation and inhibits their final differentiation, and IHH secreted by
resting and hypertrophic cells, which stimulates PTHrP expression
as a functional negative feedback [19]. Our QRT-PCR analysis in
early post-natal (6 days) mice found that IHH expression was
surprisingly increased in the BSP2/2, despite the thinner
hypertrophic zone, while PTHrP actually showed a trend to
reduction, suggesting a disruption of the feedback loop. Most
interestingly, the expression of IGF-1, a major factor inducing
both chondrocyte proliferation and hypertrophy, was found to be
severely reduced in BSP2/2 post-natal long bone. While the
interplay between circulating and local, autocrine/paracrine IGF-
1 is complex (see [20] for a recent review), it is known that tissue
IGF-1 is crucial for post natal bone growth, and that only a severe
reduction of circulating IGF-1 (down to ,15% of normal)
significantly affects mouse long bone size [21]. The reduction of
IGF-1 expression in BSP2/2 mice might thus be a major factor
explaining the slower growth of mutant skeleton. However, the
IGF-1 pathway and the IHH/PTHrP pathway have been shown
to act independently [22], suggesting a more complex picture.
That both higher IHH and lower IGF-1 expression would reflect
phenotypic alteration of hypertrophic chondrocytes, the only stage
which has been shown to express BSP, is one hypothesis to be
tested. Of note, our PCR analysis concerned whole bones, and
therefore the results did not distinguish between chondrocyte and
osteoblast contribution, e.g. to IGF-1 expression. IGF-1 is also a
major factor regulating bone formation activity, and reduction/
absence of IGF-1 signaling results in osteopenia [20], a phenotype
observed in growing BSP2/2 mice (see below).
The proliferative zone was found to be thinner at 3 weeks in
BSP2/2 than in BSP+/+ mice, suggesting that chondrocyte
proliferation/survival is altered in mutants perhaps through a
cross-talk with hypertrophic chondrocytes. The total width of the
growth plate is not altered, as the hypertrophic zone is thicker in 3
week old BSP2/2 mice. This may result at least in part from the
reduced osteoclast numbers and thus activity at this stage in the
absence of BSP [7], which could impair the proper resorption of
the cartilage template. Further studies will be needed to unravel
the multiple mechanisms through which the absence of BSP affects
the dynamic of bone growth.
The lower bone mass observed in newborn BSP2/2 mice is
congruent with the QRT-PCR results showing lower expression of
both early (Runx2, Osx) and late (Ocn, DMP1) bone formation
markers, as well as the lower levels of IGF-1 expression. We also
confirmed in this study the lower mineral density of newborn
BSP2/2 bone matrix, extending the observations to developing
digits and calvariae (Fig. 2). The higher level of MEPE expression
observed in post-natal mutant long bones is intriguing, as this
SIBLING protein, in particular through its cleavage releasing an
"Acidic Serine-Aspartate Rich MEPE associated" (ASARM)
peptide, is a potent inhibitor of matrix mineralization in bone
[23] but also in the growth plate [24]. Of note, levels of MEPE
expression in adult (2 month old) BSP2/2 bones were not found
to differ from wild type mice [25]. Opn is also a major inhibitor of
bone mineralization, as appears from the hyper-mineralized
Opn2/2 mouse bones [26], as well as the rescue of bone hypo-
Figure 6. Growth plate and osteoblast marker protein expression and blood levels in newborn and adult BSP+/+ and BSP2/2mice.
QRT-PCR was performed 6 days after birth on collected whole femurs and tibias including the growth plates, ground and extracted in Tri-reagent.
Messenger RNA expression of growth plate regulators IHH, PTHrP and IGF-1 (A), markers of bone formation Runx2, Osx and Ocn (B) and SIBLING
proteins DMP1, MEPE and Opn (C) were assessed in samples from BSP+/+ (N = 5) and BSP2/2 (N = 9) mice. Expression levels are normalized on the
housekeeping gene GAPDH, and on Runx2 levels for Opn (C). ELISA assay of Opn (D) in the serum of 6 days (N = 5 pools), 35 days and 12 month old
(N= 5 male) BSP+/+ and BSP2/2 mice. Data are Mean6SEM; *: p,0.05, **: p,0.01, ***: p,0.001 vs BSP+/+, Mann-Whitney U test.
doi:10.1371/journal.pone.0095144.g006
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Figure 7. Static histomorphometric parameters and cellular activities in femur bones from 3, 10 and 16 week old BSP+/+ (+/+) and
BSP2/2 (2/2) mice. Data are Mean6SEM of N=6 to 10 mice; *:p,0.05, **:p,0.001 vs BSP+/+, Mann-Whitney U Test.
doi:10.1371/journal.pone.0095144.g007
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mineralization induced by tissue non-specific alkaline phosphatase
(Akp2) gene knockout when these mice are crossed with the
Opn2/2 [27]. Surprisingly, Opn expression was found to be
lower in mutant long bones at day 6, while serum levels were
higher than in wild type. However, osteoblasts are a major source
of Opn in bone, and when normalized to Runx2, a marker of the
osteoblast/chondrocyte lineage Opn levels were indeed higher in
BSP2/2 mice, suggesting a relative over-expression of the
protein. Thus, the under-mineralized matrix observed in young
mice in the absence of BSP might reflect at least in part the action
of MEPE and Opn. Of note, mineralization levels progressively
equalize in aging BSP+/+ and 2/2 mice [6], which we interpret
as a main action of BSP on primary mineralization, in congruence
with the higher osteoid surfaces observed in adult long bones (see
below). Thus, the permanence of higher serum Opn levels in aging
BSP2/2 mice (Fig. 6D) suggests that its action might not be
dominant in this model, or at least not at all stages of skeletal life.
Multiple knockouts of SIBLING genes would clearly be helpful to
unravel such questions.
Bone growth in rodent is continuous, but its rate decreases with
age, along with growth plate activity, which we found to be
reduced at 10 weeks of age in the 129 sv/CD1 mice, and nearly
arrested at 16 weeks (Fig. 4). As the BSP2/2 mice grow, an
accumulation of trabecular bone is seen as early as 3 weeks after
birth, in concert with a reduction of osteoclast numbers and
surfaces, suggesting that the increase in trabecular BV/TV after
birth results at least in part from defective resorption. Lower OS/
BS are observed in 3 week and 10 week old BSP2/2 mice, likely
reflecting lower bone forming activity, as previously shown at the
peak of repair bone deposition in cortical defect repair of
BSP2/2 mice [28]. With the reduction of growth rate, the
modeling process, in which formation and resorption are
uncoupled slows down, and primary woven bone is gradually
replaced with lamellar bone, by the process of bone remodeling.
While secondary ossification progressively supersedes primary
ossification, the overall cellular activity is reduced. As previously
shown [6], in the less active, mostly remodeling trabecular bone of
16 week old BSP2/2 mice, OS/BS values are higher than in wild
type, likely reflecting delayed primary mineralization. The thinner
cortical bones observed in mutant mice at 10 and 16 weeks of age
reflect lower periosteal and endosteal BFR, as documented
elsewhere [25]. The transient thickening of the cortical bone in
3 week old BSP2/2 mice is intriguing, and may hint at a
temporary imbalance of the modeling process during the post-
natal crisis period, marked by a drop in osteoclast numbers.
Clearly, a closer analysis has to be done of the very early times of
BSP2/2 growth to assess these hypothesis.
In conclusion, we confirmed in this study that BSP plays an
important role in long bone growth kinetics, as well as
membranous/cortical primary bone formation and mineraliza-
tion. Endochondral development is however normal in BSP2/2
mice and the accumulation of trabecular bone observed in the
adults develops progressively in the weeks following birth. The
effects of the absence of BSP on chondrocyte proliferation,
differentiation and activity, the compensatory mechanisms that
allow normal endochondral bone development in BSP2/2 mice
as well as the role played by IGF-1, MEPE and Opn in the
absence of BSP will have to be explored.
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